Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EAU 2025 | Outcomes of radical prostatectomy following HIFU failure

Ludovica Cella • 21 Mar 2025
EAU 2025
Genitourinary Cancer Prostate Cancer

Ludovica Cella, MD, Humanitas University, Milan, Italy, presents results from a single-center study evaluating the feasibility, safety, and outcomes of radical prostatectomy in in patients with localised prostate cancer who experienced failure after high-intensity focused ultrasound (HIFU) treatment. Despite expected challenges such as tissue adhesions, the procedure was safely performed with no significant intraoperative complications. Post-operative recovery showed favorable functional and oncological outcomes, reinforcing the viability of surgery as a salvage option after HIFU. This interview took place at the 2025 European Association of Urology (EAU) Congress in Madrid, Spain.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Ludovica Cella

Evaluating the four-tier hybrid grading system in Ta NMIBC
1:42
Evaluating the four-tier hybrid grading system in Ta NMIBC
Ludovica Cella • 21 Mar 2025
Mental health and QoL after robotic prostatectomy in older patients
2:32
Mental health and QoL after robotic prostatectomy in older patients
Ludovica Cella • 21 Mar 2025

Related Videos

Current and emerging systemic strategies in biochemically relapsed prostate cancer
2:45
Current and emerging systemic strategies in biochemically relapsed prostate cancer
Ashwin Sachdeva • 16 May 2026
How has SABR improved radiotherapy practice in kidney cancer?
1:06
How has SABR improved radiotherapy practice in kidney cancer?
Shankar Siva • 16 May 2026
Which patients with kidney cancer may benefit from SABR treatment?
1:58
Which patients with kidney cancer may benefit from SABR treatment?
Shankar Siva • 16 May 2026
Management of brain metastasis in patients with poor-risk testicular cancer
1:03
Management of brain metastasis in patients with poor-risk testicular cancer
Darren Feldman • 30 May 2026
The content of VJOncology is intended for healthcare professionals